Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McAuliffe

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Surgery|November 7, 2006
Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioningTadashi Matsumoto, Kerri O'Malley, Philip A Efron, et al.
Breast Cancer Research and Treatment|August 19, 2015
Developing in vitro models of human ductal carcinoma in situ from primary tissue explantsDaniel D Brown, David J Dabbs, Adrian V Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective StudyLakshmi Harinath, Tatiana M Villatoro, Beth Z Clark, et al.
Psycho-Oncology|October 22, 2015
Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancerJohn D Merriman, Susan M Sereika, Adam M Brufsky, et al.
Cancer Letters|June 24, 2019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaLan Cao, Ahmed Basudan, Matthew J Sikora, et al.
Endocrinology|July 2, 2020
Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast CarcinomaSreeja Sreekumar, Kevin M Levine, Matthew J Sikora, et al.
American Journal of Clinical Pathology|May 10, 2018
Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?Alessandra Landmann, Daniel J Farrugia, Li Zhu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2020
Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancerCatherine M Bender, Susan M Sereika, Amanda L Gentry, et al.
Annals of Surgical Oncology|October 13, 2020
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)Faina Nakhlis, Gabrielle M Baker, Melissa Pilewskie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsisPhilip O Scumpia, Matthew J Delano, Kindra M Kelly, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Surgery|November 7, 2006
Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioningTadashi Matsumoto, Kerri O'Malley, Philip A Efron, et al.
Breast Cancer Research and Treatment|August 19, 2015
Developing in vitro models of human ductal carcinoma in situ from primary tissue explantsDaniel D Brown, David J Dabbs, Adrian V Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective StudyLakshmi Harinath, Tatiana M Villatoro, Beth Z Clark, et al.
Psycho-Oncology|October 22, 2015
Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancerJohn D Merriman, Susan M Sereika, Adam M Brufsky, et al.
Cancer Letters|June 24, 2019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaLan Cao, Ahmed Basudan, Matthew J Sikora, et al.
Endocrinology|July 2, 2020
Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast CarcinomaSreeja Sreekumar, Kevin M Levine, Matthew J Sikora, et al.
American Journal of Clinical Pathology|May 10, 2018
Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?Alessandra Landmann, Daniel J Farrugia, Li Zhu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2020
Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancerCatherine M Bender, Susan M Sereika, Amanda L Gentry, et al.
Annals of Surgical Oncology|October 13, 2020
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)Faina Nakhlis, Gabrielle M Baker, Melissa Pilewskie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsisPhilip O Scumpia, Matthew J Delano, Kindra M Kelly, et al.
Pageof 12